首页> 美国卫生研究院文献>Elsevier Sponsored Documents >The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial IST-3): a randomised controlled trial

【2h】

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial IST-3): a randomised controlled trial

机译：重组蛋白纤溶酶原激活剂在急性缺血性卒中后6小时内进行静脉溶栓治疗的利弊（第三项国际卒中试验IST-3）：一项随机对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Elsevier Sponsored Documents
作者

展开▼
作者单位

展开▼
年(卷),期 -1(379),9834
年度 -1
页码 2352–2363
总页数 5
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial [J] . SandercockP., WardlawJ.M., LindleyR.I., The Lancet . 2012,第9834期

机译：重组组织纤溶酶原激活剂在急性缺血性中风后6小时内进行静脉溶栓治疗的利弊（第三项国际中风试验[IST-3]）：一项随机对照试验
2. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial [J] . Wardlaw Joanna M., Sandercock Peter, Cohen Geoff, Lancet Neurology . 2015,第5期

机译：在第三次国际卒中试验（IST-3）中，脑影像体征，早期和晚期结局与急性缺血性卒中后对静脉阿替普酶的反应之间的关联：一项随机对照试验的二次分析
3. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long.term outcomes (the third International Stroke Trial [IST.3]): 18.month follow.up of a randomised controlled trial [J] . The IST-3 collaborative group Lancet Neurology . 2013,第8期

机译：急性缺血性卒中后6小时内阿替普酶溶栓对长期预后的影响（第三次国际卒中试验[IST.3]）：18个月随访。一项随机对照试验
4. Case study of patients participating in a randomised controlled trial of upper-limb robotic rehabilitation in acute stroke services [C] . Jackson A.E., Levesley M.C., Makower S.G., Proceedings of the IEEE/RAS-EMBS International Conference on Rehabilitation Robotics . 2015

机译：参加急性卒中服务中上肢机器人康复随机对照试验的患者的案例研究
5. Use of Administative Claims Data to Design and Emulate a Clinical Trial in Acute Stroke Patients Comparing Rehabilitation at Inpatient Rehabilitation Facilities to Skilled Nursing Facilities [D] . Simmonds, Kent P. 2020

机译：使用行政权利要求数据来设计和模拟急性中风患者的临床试验，比较住院康复设施的康复到熟练的护理设施
6. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial IST-3): 18-month follow-up of a randomised controlled trial [O] . -1

机译：急性缺血性卒中后6小时内阿替普酶溶栓对长期预后的影响（第三次国际卒中试验IST-3）：一项随机对照试验的18个月随访
7. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. [O] . Sandercock, P, Wardlaw, JM, Lindley, RI, 2012

机译：急性缺血性卒中后6小时内用重组组织纤溶酶原激活剂进行静脉溶栓治疗的利弊（第三项国际卒中试验[IST-3]）：一项随机对照试验。

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial IST-3): a randomised controlled trial

著录项

引文网络

相似文献

相关主题

期刊订阅